Ireland - English - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - quetiapine hemifumarate - prolonged-release tablet - 400 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine - antipsychotics; diazepines, oxazepines, thiazepines - it is indicated for treatment of schizophrenia and treatment of bipolar disorder

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine - prolonged-release tablet - 50 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine - diazepines, oxazepines, thiazepines and oxepines - quentiax sr is indicated for:
treatment of schizophrenia
treatment of bipolar disorder: for the treatment of moderate to severe manic episodes in bipolar disorder for the treatment of major depressive episodes in bipolar disorder for the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment.
add-on treatment of major depressive episodes in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1). prior to initiating treatment, clinicians should consider the safety profile of quentiax sr

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 150 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 200 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 300 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Australia - English - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: colloidal anhydrous silica; macrogol 8000; macrogol 7000000; hypromellose; butylated hydroxytoluene; iron oxide yellow; magnesium stearate - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 400 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - carbamazepine - prolonged-release tablet - 200 milligram(s) - carboxamide derivatives; carbamazepine

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - carbamazepine - prolonged-release tablet - 400 milligram(s) - carboxamide derivatives; carbamazepine

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca ab - quetiapine - prolonged-release tablet - 200 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine